Novel pyrrolidine compounds that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system (CNS) disorders, also is disclosed.
本发明公开了一种新型
吡咯烷化合物,它们是PDE4的有效和选择性
抑制剂,并公开了制备这些化合物的方法。本发明还揭示了在治疗炎症性疾病和其他涉及细胞因子
水平升高的疾病以及中枢神经系统(CNS)疾病中使用这些化合物的方法。